Next Article in Journal
Critical Considerations in the Interpretation of Bone Turnover Marker Data in Hormonal Contraceptive Users. Comment on Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. Pharmaceuticals 2025, 18, 61
Previous Article in Journal
Cardiotoxicity Induced by Anticancer Therapies: A Call for Integrated Cardio-Oncology Practice
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 18
Issue 9
10.3390/ph18091400
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Retraction of Pharmaceuticals 2024, 17(5), 549.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Naamneh et al. Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals 2024, 17, 549

by
Majdi Saleem Naamneh
1,
Tatjana Momic
1,2,
Michal Klazas
1,
Julius Grosche
3,
Johannes A. Eble
3,
Cezary Marcinkiewicz
4,
Netaly Khazanov
5,
Hanoch Senderowitz
5,
Amnon Hoffman
1,
Chaim Gilon
6,
Jehoshua Katzhendler
1,† and
Philip Lazarovici
1,*
1
School of Pharmacy Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112002, Israel
2
VINČA Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Mike Petrovića Alasa 12–14, 11000 Belgrade, Serbia
3
Institute of Physiological Chemistry and Pathobiochemistry, University of Münster, Waldeyer-Str. 15, 48149 Münster, Germany
4
Debina Diagnostics Inc., 33 Bishop Hollow Rd., Newtown Square, PA 19073-3211, USA
5
Department of Chemistry, Bar Ilan University, Ramat-Gan 5290002, Israel
6
Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel
*
Author to whom correspondence should be addressed.
†
Dedicated to the memory of deceased J. K. that enriched the lives of all of us who were privileged to know and work with him.
Pharmaceuticals 2025, 18(9), 1400; https://doi.org/10.3390/ph18091400
Submission received: 21 August 2025 / Accepted: 3 September 2025 / Published: 18 September 2025
Versions Notes
The journal retracts the article titled “Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities” [1], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding a range of image irregularities contained within this article [1].
Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board that identified indications of inappropriate editing and partial duplication between figures presented in this article [1] and earlier publications [2,3], produced by a different research group. While the authors collaborated within this process, raw material meeting the journal’s requirements for original images could not be provided for Editorial Board evaluation (https://www.mdpi.com/journal/molecules/instructions#oriimages, accessed on 20 August 2025). Consequently, the Editorial Board has lost confidence in the reliability of the findings and has decided to retract this publication, as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 20 August 2025).
This retraction was approved by the Editor-in-Chief of the Pharmaceuticals journal.
Johannes A. Eble agrees to this retraction. The remaining authors disagree with this retraction.

References

  1. Naamneh, M.S.; Momic, T.; Klazas, M.; Grosche, J.; Eble, J.A.; Marcinkiewicz, C.; Khazanov, N.; Senderowitz, H.; Hoffman, A.; Gilon, C.; et al. RETRACTED: Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals 2024, 17, 549. [Google Scholar] [CrossRef] [PubMed]
  2. Available online: https://www.nature.com/articles/s41598-022-25937-1 (accessed on 20 August 2025).
  3. Available online: https://link.springer.com/article/10.1186/1756-9966-29-46 (accessed on 20 August 2025).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Naamneh, M.S.; Momic, T.; Klazas, M.; Grosche, J.; Eble, J.A.; Marcinkiewicz, C.; Khazanov, N.; Senderowitz, H.; Hoffman, A.; Gilon, C.; et al. RETRACTED: Naamneh et al. Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals 2024, 17, 549. Pharmaceuticals 2025, 18, 1400. https://doi.org/10.3390/ph18091400

AMA Style

Naamneh MS, Momic T, Klazas M, Grosche J, Eble JA, Marcinkiewicz C, Khazanov N, Senderowitz H, Hoffman A, Gilon C, et al. RETRACTED: Naamneh et al. Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals 2024, 17, 549. Pharmaceuticals. 2025; 18(9):1400. https://doi.org/10.3390/ph18091400

Chicago/Turabian Style

Naamneh, Majdi Saleem, Tatjana Momic, Michal Klazas, Julius Grosche, Johannes A. Eble, Cezary Marcinkiewicz, Netaly Khazanov, Hanoch Senderowitz, Amnon Hoffman, Chaim Gilon, and et al. 2025. "RETRACTED: Naamneh et al. Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals 2024, 17, 549" Pharmaceuticals 18, no. 9: 1400. https://doi.org/10.3390/ph18091400

APA Style

Naamneh, M. S., Momic, T., Klazas, M., Grosche, J., Eble, J. A., Marcinkiewicz, C., Khazanov, N., Senderowitz, H., Hoffman, A., Gilon, C., Katzhendler, J., & Lazarovici, P. (2025). RETRACTED: Naamneh et al. Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals 2024, 17, 549. Pharmaceuticals, 18(9), 1400. https://doi.org/10.3390/ph18091400

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop